{"id":"W4386281969","doi":"10.1016/s2152-2650(23)01441-6","title":"MM-360 Mezigdomide (MEZI) Plus Dexamethasone (DEX) in Relapsed/refractory Multiple Myeloma (RRMM): Results From the Dose-Expansion Phase of the CC-92480-MM-001 Trial","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Dexamethasone; Multiple myeloma; Medicine; Phase (matter); Oncology; Nuclear medicine; Internal medicine; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100943,0.0008224294,0.001648178,0.0002777914,0.0002350419,0.0009132404,0.0007013899,0.0007175752,0.003002704],"category_scores_gemma":[0.0007841248,0.0002740656,0.001247152,0.0004035389,0.0005495803,0.0006795783,0.0003805027,0.003319678,0.0008083886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008974471,"about_ca_system_score_gemma":0.000805611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001765316,"about_ca_topic_score_gemma":0.004076268,"domain_scores_codex":[0.9996358,0.0001754069,0.0000149636,0.00005621412,0.00003640119,0.00008114077],"domain_scores_gemma":[0.9996021,0.00007924579,0.00007784774,0.00003072565,0.00001782718,0.0001922466],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7089589,0.01001302,0.004485694,0.00114814,0.002273642,0.0001154755,0.0002104435,0.002797222,0.0170298,0.000648707,0.007890749,0.2444282],"study_design_scores_gemma":[0.7444197,0.2054031,0.03061219,0.0002087591,0.002106152,0.0003857627,0.0001596494,0.001700317,0.003560395,0.0007994992,0.01057752,0.00006691695],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9793766,0.01375512,0.0003341085,0.001299806,0.0001981743,0.000448215,0.001326963,0.0001436019,0.003117567],"genre_scores_gemma":[0.9850059,0.006527491,0.0009582454,0.001321119,0.0001914993,0.0003429991,0.002491159,0.0000445757,0.00311699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003002704,"threshold_uncertainty_score":0.01004505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09324318455389913,"score_gpt":0.3844113765912489,"score_spread":0.2911681920373498,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}